Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ProteomTech Inc.
ProteomTech Inc. has developed a protocol for speeding up the protein refolding process so it can be completed in 24-to-48 hours. It's strategy for generating revenues includes contract manufacturing for the research market, a service business that may one day grow to include manufacture of protein drugs
Should a disruptive protein production technology emerge, the current interest in developing large-molecule therapeutics assures there would be many takers.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Protein Manufacturing Start-Ups, features profiles of Chesapeake PERL Inc., Chlorogen Inc., ProteomTech Inc. and Psyche Pharmaceuticals Inc. Plus these Start-Ups Across Health Care: ArgoLink Inc., Confirma Inc., FivePrime Therapeutics Inc. and QuantomiX Ltd.
- Large Molecule
Drug Discovery Tools
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.